Polina Ilina

Dr. Polina Ilina


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2012 in Journal of Controlled Release
Verified
Journal Article
Closed access
PIPolina Ilina
Polina Ilina
ZHZanna Hyvonen
Zanna Hyvonen
MSMaeva Saura
Maeva Saura
KSKirsten Sandvig
Kirsten Sandvig
MYMarjo Yliperttula
Marjo Yliperttula
MRMarika Ruponen
Marika Ruponen

1 March 2015 in Experimental Cell Research
Verified
Journal Article
Closed access
PIPolina Ilina
Polina Ilina
SPSusanna Partti
Susanna Partti
JNJohanna Niklander
Johanna Niklander
MRMarika Ruponen
Marika Ruponen
Yan-Ru LouYan-Ru Lou
Yan-Ru Lou
MYMarjo Yliperttula
Marjo Yliperttula

Verified
Journal Article
Open access
PDF file
VGViviana Gatta
Viviana Gatta
PIPolina Ilina
Polina Ilina
APAlison Porter
Alison Porter
SMStuart McElroy
Stuart McElroy
PTPäivi Tammela
Päivi Tammela
Since quorum sensing (QS) is linked to the establishment of bacterial infection, its inactivation represents one of the newest strategies to fight bacterial pathogens. LsrK is a kinase playing a key role in the processing of autoinducer-2 (AI-2), a quorum-sensing mediator in gut enteric bacteria. Inhibition of LsrK might thus impair the quorum-sensing cascade and consequently reduce bacterial pathogenicity. Aiming for the development of a target-based assay for the discovery of LsrK inhibitors, we evaluated different assay set-ups based on ATP detection and optimized an automation-compatible method for the high-throughput screening of chemical libraries. The assay was then used to perform the screening of a 2000-compound library, which provided 12 active compounds with an IC50 ≤ 10 µM confirming the effectiveness and sensitivity of our assay. Follow-up studies on the positive hits led to the identification of two compounds, harpagoside and rosolic acid, active in a cell-based AI-2 QS interference assay, which are at the moment the most promising candidates for the development of a new class of antivirulence agents based on LsrK inhibition.

5 July 2024 in Archives of Microbiology
Verified
Journal Article
Open access
PDF file
MLM. Li
M. Li
CCCristina Durante Cruz
Cristina Durante Cruz
PIPolina Ilina
Polina Ilina
PTPäivi Tammela
Päivi Tammela
Uropathogenic Escherichia coli, the most common cause for urinary tract infections, forms biofilm enhancing its antibiotic resistance. To assess the effects of compounds on biofilm formation of uropathogenic Escherichia coli UMN026 strain, a high-throughput combination assay using resazurin followed by crystal violet staining was optimized for 384-well microplate. Optimized assay parameters included, for example, resazurin and crystal violet concentrations, and incubation time for readouts. For the assay validation, quality parameters Z′ factor, coefficient of variation, signal-to-noise, and signal-to-background were calculated. Microplate uniformity, signal variability, edge well effects, and fold shift were also assessed. Finally, a screening with known antibacterial compounds was conducted to evaluate the assay performance. The best conditions found were achieved by using 12 µg/mL resazurin for 150 min and 0.023% crystal violet. This assay was able to detect compounds displaying antibiofilm activity against UMN026 strain at sub-inhibitory concentrations, in terms of metabolic activity and/or biomass. Graphical Abstract

1 November 2018 in Journal of Microbiological Methods
Verified
Journal Article
Open access
PIPolina Ilina
Polina Ilina
XMXiaochu Ma
Xiaochu Ma
HSHerman O. Sintim
Herman O. Sintim
PTPäivi Tammela
Päivi Tammela
The continuing emergence and spread of antibiotic-resistant bacteria is worrisome and new strategies to curb bacterial infections are being sought. The interference of bacterial quorum sensing (QS) signaling has been suggested as a prospective antivirulence strategy. The AI-2 QS system is present in multiple bacterial species and has been shown to be correlated with pathogenicity. To facilitate the discovery of novel compounds interfering with AI-2 QS, we established a high-throughput setup of whole-cell bioreporter assay, which can be performed in either 96- or 384-well format. Agonistic or antagonistic activities of the test compounds against Escherichia coli LsrB-type AI-2 QS system are monitored by measuring the level of β-galactosidase expression. A control strain expressing β-galactosidase in quorum sensing-independent manner is included into the assay for false-positive detection.

3 December 2018 in Marine Drugs
Verified
Journal Article
Open access
PDF file
CBChinmay Bhat
Chinmay Bhat
PIPolina Ilina
Polina Ilina
ITIrene Tilli
Irene Tilli
MVManuela Voráčová
Manuela Voráčová
TBTanja Riina Bruun
Tanja Riina Bruun
PTPäivi Tammela
Päivi Tammela
The first total synthesis of the marine bromotyrosine purpurealidin I (1) using trifluoroacetoxy protection group and its dimethylated analog (29) is reported along with 16 simplified bromotyrosine derivatives lacking the tyramine moiety. Their cytotoxicity was evaluated against the human malignant melanoma cell line (A-375) and normal skin fibroblast cells (Hs27) together with 33 purpurealidin-inspired simplified amides, and the structure–activity relationships were investigated. The synthesized simplified analogs without the tyramine part retained the cytotoxic activity. Purpurealidin I (1) showed no selectivity but its simplified pyridin-2-yl derivative (36) had the best improvement in selectivity (Selectivity index 4.1). This shows that the marine bromotyrosines are promising scaffolds for developing cytotoxic agents and the full understanding of the elements of their SAR and improving the selectivity requires further optimization of simplified bromotyrosine derivatives.